Decheng Capital LLC Pyxis Oncology, Inc. Transaction History
Decheng Capital LLC
- $422 Billion
- Q3 2024
A detailed history of Decheng Capital LLC transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Decheng Capital LLC holds 326,810 shares of PYXS stock, worth $1.33 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
326,810
Previous 326,810
-0.0%
Holding current value
$1.33 Million
Previous $1.08 Billion
10.88%
% of portfolio
0.28%
Previous 0.33%
Shares
1 transactions
Others Institutions Holding PYXS
# of Institutions
101Shares Held
28.2MCall Options Held
539KPut Options Held
54.1K-
Deep Track Capital, LP Greenwich, CT4.18MShares$17 Million0.57% of portfolio
-
Laurion Capital Management LP New York, NY3.63MShares$14.8 Million0.18% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$11.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$9.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.91MShares$7.76 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $143M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...